Katharine Bray-French

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Immune Response

High Throughput Sequencing

Dendritic Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Katharina Hartman, Guido Steiner, Michel Siegel, Cary M Looney, Timothy P Hickling, Katharine Bray-French, Sebastian Springer, Céline Marban-Doran, Axel Ducret
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes. Biology 12 (9) (2023)
Michel Siegel, Guido Steiner, Linnea C Franssen, Francesca Carratu, James Herron, Katharina Hartman, Cary M Looney, Axel Ducret, Katharine Bray-French, Olivier Rohr, Timothy P Hickling, Noel Smith, Céline Marban-Doran
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics. Pharmaceutics 14 (12) (2022)
Michel Siegel, Guido Steiner, Linnea C Franssen, Francesca Carratu, James Herron, Katharina Hartman, Cary M Looney, Axel Ducret, Katharine Bray-French, Olivier Rohr, Timothy P Hickling, Noel Smith, Céline Marban-Doran
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics. Pharmaceutics 14 (12) (2022)
Michel Siegel, Guido Steiner, Linnea C Franssen, Francesca Carratu, James Herron, Katharina Hartman, Cary M Looney, Axel Ducret, Katharine Bray-French, Olivier Rohr, Timothy P Hickling, Noel Smith, Céline Marban-Doran
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics. Pharmaceutics 14 (12) (2022)